News

Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin in the US, with an option for global rights. Urocidin is a patented formulation of

Forest Laboratories and its wholly-owned subsidiary, Forest Laboratories Holdings and Lundbeck have entered into a settlement agreement with Sun Pharma and Caraco, regarding pending patent infringement disputes. Its

The supervisory board of Celesio has approved the majority holding of 50.1% in pharmaceutical wholesaler Panpharma. The company said that it has spent about two years thoroughly analysing

HST Global has announced the termination of its Letter of Intent Agreement to purchase Bryomed International. HST Global looks forward to maintaining the relationship between the parties and

Medtronic has initiated a recall of specific lots of Quick-set infusion sets that are used with MiniMed Paradigm insulin pumps. Affected infusion sets are reference numbers MMT-396, MMT-397,

Dharma Therapeutics’ active transdermal delivery technology, which administers lidocaine and epinephrine through the skin via a mild electric current, has demonstrated safety and efficacy in a phase 2

Aurobindo Pharma has received final approval for Fosinopril Sodium and Hydrochlorothiazide Tablets (USP 10/12.5mg and 20/12.5mg) from the FDA. Fosinopril Sodium and Hydrochlorothiazide Tablets USP 10/12.5mg and 20/12.5mg

Bayer Vital is going to launch the OTC Proton Pump Inhibitor (PPI), omeprazole in Germany under the Antra brand, beginning in August. With Antra, patients would have a

Amarillo has completed the enrollment procedure in a Phase 2 clinical study of the oral interferon product at the University of Western Australia. The company said that a